| 1. |
 |
Chambers TP, et al.
Toxicology. 2017 May 1;382:24-35.
|
Imatinib Mesylate | Oxygen | Rotenone | Thapsigargin |
CANX | CASP3 | CASP7 | CASP9 | DDIT3 | ERO1A | HSPA5 | SH3BP5 |
|
| 2. |
 |
Das S, et al.
Environ Toxicol. 2017 Feb;32(2):630-644.
|
mangiferin | Methylmercury Compounds | Rotenone |
DNM1L | GSR |
|
| 3. |
 |
Guan Q, et al.
Neurochem Res. 2017 Feb;42(2):572-582.
|
Rotenone |
ADAMTS1 | ATP1A2 | BHLHE40 | CCL6 | CLDN11 | EFNB3 | ETS1 | FMOD | FTL1 | GAS7 | GDF15 | IGF2 | LARP7 | LGALS3 | LTBP2 | MAPK9 | MBP | MGLL | MGP | NNAT | NPY | ODC1 | ODF2 | OGN | PDE10A | PPP3R1 | PTX3 | RGD1311744 | RUFY2 | SERPINE1 | SERPINE2 | SGK1 | SPP1 | TLE4 | TNNT2 | UGT8 | WARS | WISP2 | XRCC6 |
|
| 4. |
 |
Hsu YC, et al.
Environ Toxicol. 2017 Jan;32(1):84-98.
|
deguelin |
AIFM1 | BAK1 | BAX | BCL2 | BCL2L1 | CASP3 |
|
| 5. |
 |
Ishido M, et al.
Toxicol Lett. 2017 Jan 15;266:42-48.
|
Rotenone |
ABCG5 | ANAPC1 | BAZ1B | CALCRL | CCR3 | DHRS7 | DNAH7 | EML4 | GRIFIN | HSPA1A | IGFBP5 | KLF2 | LILRB3 | PRKCD | RNF138 | SSPN | SULT1E1 | TNN | TNNT2 | TP53INP1 | WISP2 |
Attention Deficit Disorder with Hyperactivity | Hyperkinesis |
| 6. |
 |
Naughton C, et al.
Behav Brain Res. 2017 Jan 1;316:160-168.
|
Rotenone |
SNCA |
Nerve Degeneration |
| 7. |
 |
Tak E, et al.
Toxicol Appl Pharmacol. 2017 Jan 1;314:72-81.
|
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | cobaltous chloride | deguelin | Oxygen | Thioacetamide |
ENTPD1 | HIF1A | NT5E |
Disease Models, Animal | Liver Failure, Acute |
| 8. |
 |
Wang Y, et al.
Toxicol Appl Pharmacol. 2017 May 1;322:51-59.
|
Rotenone | Soot |
CYBB | ITGAM | NCF1 | NCF4 |
|
| 9. |
 |
Zhang XL, et al.
Toxicol Lett. 2017 Apr 5;271:74-83.
|
1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one | Bibenzyls | Rotenone |
AKT1 | GSK3B | HMOX1 | NFE2L2 | PARK7 |
|
| 10. |
 |
Abdelkader NF, et al.
Mol Neurobiol. 2016 Mar;53(2):810-7.
|
Rotenone | Ursodeoxycholic Acid |
BAX | BCL2 | CASP3 | CASP8 | CASP9 | IL10 | IL1B | NFKB1 | TNF |
Movement Disorders |
| 11. |
 |
Chen YJ, et al.
Nanotechnology. 2016 Apr 22;27(16):164001.
|
Rotenone | Staurosporine |
CASP3 | SNCA |
|
| 12. |
 |
El-Horany HE, et al.
J Biochem Mol Toxicol. 2016 Jul;30(7):360-9.
|
Apomorphine | Quercetin | Rotenone |
BECN1 | DDIT3 |
Catalepsy | Disease Models, Animal | Gliosis | Movement Disorders | Necrosis | Parkinsonian Disorders | Weight Loss |
| 13. |
 |
Gaballah HH, et al.
Chem Biol Interact. 2016 May 5;251:10-6.
|
resveratrol | Rotenone |
CASP3 | DDIT3 | HSPA5 | IL1B | NFE2L2 | XDH |
Catalepsy | Motor Disorders | Parkinsonian Disorders |
| 14. |
 |
Goswami P, et al.
Mol Neurobiol. 2016 Jan;53(1):285-298.
|
Rotenone | salubrinal |
CASP12 | CASP3 | CASP9 | DDIT3 | EIF2S1 | HSPA5 |
Chromosome Breakage |
| 15. |
 |
Huang JY, et al.
Acta Pharmacol Sin. 2016 Jun;37(6):731-40.
|
Bibenzyls | Rotenone |
BAX | BCL2 | CASP3 | HMOX1 | NFE2L2 | NQO1 |
Parkinsonian Disorders |
| 16. |
 |
Liu J, et al.
Sci Rep. 2016 Feb 5;6:20639.
|
Chloroquine | Rotenone | wortmannin |
BECN1 | CASP1 | CASP3 | IL1RN | IRAK3 | MAP1LC3B |
|
| 17. |
 |
Pan PK, et al.
Cell Mol Biol (Noisy-le-grand). 2016 Dec 30;62(14):11-17.
|
Rotenone | safranal |
GCLC | HMOX1 | KEAP1 | NFE2L2 | NQO1 |
|
| 18. |
 |
Peng K, et al.
Oxid Med Cell Longev. 2016;2016:6705621.
|
resveratrol | Rotenone |
DNM1L | FIS1 | MFN2 | OPA1 | PPARGC1A | TFAM |
Motor Disorders |
| 19. |
 |
Sala G, et al.
Neurotoxicology. 2016 May;54:161-9.
|
3-methyladenine | Rotenone |
HSPA8 | SNCA |
|
| 20. |
 |
Wise JP JR, et al.
Toxicol Sci. 2016 Oct;153(2):372-81.
|
Rotenone |
OPTN |
Parkinson Disease |
| 21. |
 |
Yalçınkaya N, et al.
Neurosci Lett. 2016 Feb 26;615:72-7.
|
Rotenone |
AIFM1 | AKT1 | BCL2 | PARK7 | PTEN |
Disease Models, Animal | Parkinsonian Disorders |
| 22. |
 |
Zhang JY, et al.
Neurochem Res. 2016 Jul;41(7):1761-73.
|
Rotenone |
SIRT3 | SNCA |
|
| 23. |
 |
Zhang L, et al.
PLoS One. 2016;11(4):e0152931.
|
Lithium Chloride | Rotenone | SB 216763 |
CASP3 | CTNNB1 | NR4A2 |
|
| 24. |
 |
Chiu CC, et al.
Exp Neurol. 2015 Jan;263:244-53.
|
4-hydroxy-2-nonenal | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | Rotenone |
ALDH2 | BAX | CASP3 | CASP9 |
|
| 25. |
 |
Choi WS, et al.
Toxicology. 2015 Feb 3;328:75-81.
|
anthra(1,9-cd)pyrazol-6(2H)-one | Rotenone |
CASP3 | MAPK10 | SLC18A2 |
|
| 26. |
 |
Fan F, et al.
Toxicol Sci. 2015 Jun;145(2):283-95.
|
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | adefovir dipivoxil | Amlodipine | Amsacrine | aprepitant | artesunate | Estradiol | Betamethasone | bexarotene | bicalutamide | Bortezomib | Budesonide | Camptothecin | ciclesonide | ciclopirox | Clomiphene | Clomipramine | Colchicine | Danazol | Digitoxin | Domperidone | Doxorubicin | dronedarone | Duloxetine Hydrochloride | Emetine | Epirubicin | Ethinyl Estradiol | etoposide phosphate | exemestane | Ezetimibe | flunisolide | Flutamide | Fluticasone | fulvestrant | gemcitabine | Gestodene | Itraconazole | latoconazole | Loteprednol Etabonate | Mebendazole | Medroxyprogesterone | Megestrol Acetate | Methotrexate | Methylprednisolone | Mifepristone | MK 2206 | mycophenolate mofetil | 1-Naphthylisothiocyanate | Nebivolol | nitazoxanide | Nitrazepam | Norethindrone | norethindrone acetate | Oseltamivir | oxaliplatin | Oxymetholone | Paroxetine | pazopanib | Pentamidine | Prednisolone | Prochlorperazine | rifapentine | Rotenone | rubitecan | Staurosporine | sunitinib | Tamoxifen | tegaserod | telithromycin | temsirolimus | Teniposide | Testosterone | TG101348 | Ticlopidine | tolcapone | Toremifene | Triamcinolone | Valinomycin | verlukast | Vincristine | vorinostat | wortmannin |
AR | ESR1 | ESR2 | PGR | THRA | THRB |
|
| 27. |
 |
Feng Y, et al.
J Neurochem. 2015 Aug;134(4):668-76.
|
resveratrol | Rotenone |
BAX | BCL2 | SIRT1 | TP53 |
|
| 28. |
 |
Furlong M, et al.
Environ Int. 2015 Feb;75:144-50.
|
Paraquat | Permethrin | Rotenone | Trifluralin |
|
Parkinson Disease |
| 29. |
 |
Guo J, et al.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Dec;40(12):1285-91.
|
Rotenone |
PARK7 |
|
| 30. |
 |
Hou YS, et al.
Mol Cell Biol. 2015 Aug;35(16):2740-51.
|
bafilomycin A1 | Metformin | pifithrin | Rotenone |
BAX | CASP3 | RPS6KB1 | SESN2 | SNCA | SQSTM1 | TRP53 |
|
| 31. |
 |
Khalil WK, et al.
Neurochem Int. 2015 Jan;80:79-86.
|
Rotenone |
BAX | BCL2 | CASP3 | TNF |
Neurobehavioral Manifestations |
| 32. |
 |
Kumar D, et al.
Oncotarget. 2015 Feb 20;6(5):3280-91.
|
Rotenone |
ATG7 | CD63 | CD81 | CD9 | PDCD6IP | TSG101 |
|
| 33. |
 |
Liang S, et al.
Toxicol Lett. 2015 May 5;234(3):162-71.
|
Rotenone |
ATG5 | BECN1 | CASP3 | GAPDH | SQSTM1 | TP53 |
Necrosis |
| 34. |
 |
Liang Y, et al.
Brain Res. 2015 Oct 5;1622:43-50.
|
Acetylcysteine | Adenosine Triphosphate | L 709049 | Lipopolysaccharides | Rifampin | Rotenone |
CASP1 | IL1B | NLRP3 |
|
| 35. |
 |
Lu J, et al.
Neurotoxicol Teratol. 2015;47:16-24.
|
CGP 42112A | PD 123319 | Rotenone |
AGT | AGTR2 | AGTRAP | NOX1 | NOX2 | NOX4 |
Disease Models, Animal | Parkinsonian Disorders |
| 36. |
 |
Mattam U, et al.
Biogerontology. 2015 Feb;16(1):109-23.
|
Melatonin | Rotenone |
ARNTL | CRY1 | CRY2 | PER1 | PER2 | SNCA | TH |
Disease Models, Animal | Parkinsonian Disorders |
| 37. |
 |
Nassar NN, et al.
Neuropharmacology. 2015 Feb;89:308-17.
|
Rotenone | saxagliptin |
BCL2 | BDNF | CASP3 | CYCS | DPP4 | ICAM1 | MPO | NFE2L2 | NOS2 | RELA | TH | TNF |
Motor Skills Disorders | Muscle Rigidity | Parkinson Disease, Secondary | Weight Loss |
| 38. |
 |
Qin J, et al.
Toxicol Lett. 2015 Nov 4;238(3):70-82.
|
PQQ Cofactor | Rotenone |
BAX | BCL2 | DIABLO | GCLC | HMOX1 | NDUFS1 | NDUFS2 | NDUFS3 | NDUFS4 | SLC18A2 | TH |
Parkinson Disease, Secondary |
| 39. |
 |
Rao SV, et al.
Neurotoxicology. 2015 Dec 17;52:230-242.
|
crocin | Paraquat | Plant Extracts | Rotenone |
ACHE | CAT |
Parkinsonian Disorders |
| 40. |
 |
Rios FJ, et al.
J Pharmacol Exp Ther. 2015 Apr;353(1):27-34.
|
2-acetylphenothiazine | Acetylcysteine | Aldosterone | anacetrapib | dalcetrapib | GKT137831 | NSC 74859 | Rotenone | torcetrapib |
AGT | CETP | CREB1 | CYBB | CYP11B1 | CYP11B2 | NOX1 | NOX4 | NOX5 | NR3C1 | NR3C2 | NR4A2 | PPARG | RARRES2 | STAR | STAT3 |
|
| 41. |
 |
Singh AK, et al.
Exp Gerontol. 2015 Jun;66:1-9.
|
PQQ Cofactor | Rotenone |
ACOX1 | CAT | FASN | PPARGC1A | SOD2 | TFAM |
|
| 42. |
 |
Yi S, et al.
Ann Hematol. 2015 Feb;94(2):201-10.
|
deguelin |
CASP3 | CASP6 | CASP8 | CD14 | CDKN1A | CEBPA | ITGAM | NPM1 | PARP1 | TP53 |
|
| 43. |
 |
Yuan YH, et al.
Toxicol Lett. 2015 Mar 4;233(2):163-71.
|
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | Lithium | Rotenone |
AKT1 | GSK3B | SNCA |
|
| 44. |
 |
Zhang Y, et al.
Sci Rep. 2015 Jul 24;5:12480.
|
Dinoprostone | Rotenone |
AGT | EDN1 | NOS2 | NOS3 | NPPA | NPPB | NPPC | SCNN1G |
Ureteral Obstruction |
| 45. |
 |
Zhao H, et al.
Int J Clin Exp Pathol. 2015;8(12):15582-90.
|
deguelin |
CD44 | ENO2 | MMP2 | MMP9 | RAC1 | ROCK1 | SERPINB3 |
Neoplasm Invasiveness |
| 46. |
 |
Zharikov AD, et al.
J Clin Invest. 2015 Jul 1;125(7):2721-35.
|
Dopamine | Rotenone |
SNCA | TH |
Disease Models, Animal | Mitochondrial Diseases | Neurodegenerative Diseases | Parkinson Disease, Secondary | Parkinsonian Disorders |
| 47. |
 |
Zhou Q, et al.
Toxicol Sci. 2015 Jan;143(1):81-96.
|
Hydrogen Peroxide | Rotenone |
CASP3 | CAT | EIF4EBP1 | MTOR | PARP1 | RPS6KB1 |
|
| 48. |
 |
Ai Q, et al.
Int Immunopharmacol. 2014 Jul;21(1):200-7.
|
Galactosamine | lipopolysaccharide, E coli O55-B5 | Rotenone |
CASP3 | CASP8 | CASP9 | GPT | IL6 | TNF |
Liver Failure, Acute |
| 49. |
 |
Cheng SY, et al.
J Biochem Mol Toxicol. 2014 Jul;28(7):302-11.
|
Ditiocarb | mancozeb | Maneb | 1-Methyl-4-phenylpyridinium | Oxidopamine | Oxygen | Rotenone |
DDIT4 |
|
| 50. |
 |
Cleaver JE, et al.
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13487-92.
|
Hydrogen Peroxide | potassium bromate | Rotenone | veliparib |
ERCC6 | H2AFX |
|